Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma binding of disopyramide.

Literature DB >> 7387819

Plasma binding of disopyramide.

B M David, B W Madsen, K F Ilett.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1980 PMID： 7387819 PMCID： PMC1430006 DOI： 10.1111/j.1365-2125.1980.tb01090.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

13 in total

1. Equilibrium dialysis and circular dichroic analysis of the novobiocin-human serum albumin complex.

Authors: J G Brand; T Y Toribara
Journal: Arch Biochem Biophys Date: 1975-03 Impact factor: 4.013

2. The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.

Authors: J W Ward; G R Kinghorn
Journal: J Int Med Res Date: 1976 Impact factor: 1.671

3. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.

Authors: P H Hinderling; E R Garrett
Journal: J Pharmacokinet Biopharm Date: 1976-06

4. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.

Authors: J L Cunningham; D D Shen; I Shudo; D L Azarnoff
Journal: Clin Pharmacokinet Date: 1977 Sep-Oct Impact factor: 6.447

5. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.

Authors: A Karim; C Kook; R L Novotney; J Zagarella; J Campion
Journal: Drug Metab Dispos Date: 1978 May-Jun Impact factor: 3.922

6. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.

Authors: P H Hinderling; J Bres; E R Garrett
Journal: J Pharm Sci Date: 1974-11 Impact factor: 3.534

7. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins.

Authors: Y W Chien; H J Lambert; A Karim
Journal: J Pharm Sci Date: 1974-12 Impact factor: 3.534

8. Sequential changes of plasma proteins after myocardial infarction.

Authors: B G Johansson; C O Kindmark; E Y Trell; F A Wollheim
Journal: Scand J Clin Lab Invest Suppl Date: 1972

9. Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate.

Authors: O Borgå; K M Piafsky; O G Nilsen
Journal: Clin Pharmacol Ther Date: 1977-11 Impact factor: 6.875

10. Acute-phase proteins from the liver and enzymes from myocardial infarction; a quantitative relationship.

Authors: S J Smith; G Bos; M R Esseveld; H G Van Eijk; J Gerbrandy
Journal: Clin Chim Acta Date: 1977-11-15 Impact factor: 3.786

11 in total

Review 1. Therapeutic drug monitoring: antiarrhythmic drugs.

Authors: T J Campbell; K M Williams
Journal: Br J Clin Pharmacol Date: 1998-10 Impact factor: 4.335

2. Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide.

Authors: D W Holt; A M Hayler; G F Healey
Journal: Br J Clin Pharmacol Date: 1983-09 Impact factor: 4.335

Review 3. Clinical pharmacokinetics of disopyramide.

Authors: A Karim; C Nissen; D L Azarnoff
Journal: J Pharmacokinet Biopharm Date: 1982-10

4. Pharmacokinetic-pharmacodynamic analysis of unbound disopyramide directly measured in serial plasma samples in man.

Authors: M Thibonnier; N H Holford; R A Upton; C D Blume; R L Williams
Journal: J Pharmacokinet Biopharm Date: 1984-12

5. Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood.

Authors: J E Bredesen; P Kierulf
Journal: Br J Clin Pharmacol Date: 1986-09 Impact factor: 4.335

6. Disopyramide protein binding in plasma from patients with nephrotic syndrome during the exacerbation and remission phases.

Authors: H Echizen; S Saima; T Ishizaki
Journal: Br J Clin Pharmacol Date: 1987-08 Impact factor: 4.335